12 Best Healthcare Stocks to Buy for 2026

Page 7 of 11

5. Edwards Lifesciences Corporation (NYSE:EW)

1-Year Gain: 23.22%

Upside Potential: 17.02%

Number of Hedge Fund Holders: 64

Edwards Lifesciences Corporation (NYSE:EW) is one of the best healthcare stocks to buy for 2026. On January 20, Stifel raised its price target of Edwards Lifesciences Corporation (NYSE:EW) to $110 from $105 while reiterating a Buy rating.

The price target hike is in response to a significant increase in the number of Transcatheter Aortic Valve Replacement (TAVR) procedures. After surveying physicians who perform the procedure, the results indicate significant growth in TAVR. Likewise, the results point to improvement in TAVR market fundamentals. The results align with the company’s revenue growing by 10% in the third quarter, driven by growth in the TAVR division, which accounts for 75% of total revenue. It is the strongest growth for the division in recent years.

Earlier, on January 9, TD Cowen upgraded Edwards Lifesciences to a Buy from Hold and raised the price target to $97 from $90. The price target hike is in response to the company entering what the research firm touts as a renewed growth cycle, driven by expanded indications for transcatheter aortic valve replacement (TAVR).

Edwards Lifesciences Corporation (NYSE:EW) is a medical technology company that develops and provides patient-focused innovations for heart conditions, specializing in structural heart disease (artificial heart valves, repair devices for mitral/tricuspid valves) and critical care monitoring.

Page 7 of 11